Ziekenhuis Oost Limburg

At Ziekenhuis Oost Limburg in Genk, clinical research in cardiovascular diseases focuses on major conditions such as acute coronary syndrome, myocardial infarction, atrial fibrillation, coronary artery disease, and heart failure. These studies are designed to test new ways to lower the risk of serious heart and blood vessel events, improve prevention, and support better long-term outcomes for patients.

• Prevention of major cardiovascular events in people at high risk
• Treatment strategies for atrial fibrillation and stroke prevention
• New approaches for coronary artery disease, acute myocardial infarction, and related complications
• Evaluation of therapies for clotting, bleeding risk, and post-procedure cardiovascular care

The site’s work in this field also includes research on lipid-related risk, thrombosis, and recovery after cardiac procedures, reflecting a strong focus on both prevention and treatment effectiveness.

Research in congenital, hereditary, and neonatal diseases includes studies on congenital CMV infection and prevention of mother-to-child transmission during pregnancy. This area aims to improve early protection for newborns and reduce the impact of infections that can affect development before or shortly after birth.

• Prevention of congenital cytomegalovirus transmission
• Maternal infection studies focused on protecting the unborn child
• Early-life disease prevention and neonatal health support

This research reflects an important pediatric and family-centered focus at the Kinderneurologie department, with the goal of improving outcomes for infants at risk.

The site is also involved in trials for digestive system diseases, especially hepatic encephalopathy and Crohn’s disease. These studies explore better ways to delay disease worsening, reduce postoperative recurrence, and improve quality of life for people living with chronic gastrointestinal and liver conditions.

• Treatment options for hepatic encephalopathy in cirrhosis
• Prevention of recurrence after surgery for Crohn’s disease
• Research aimed at improving symptom control and long-term digestive health

By studying both liver-related complications and inflammatory bowel disease, Ziekenhuis Oost Limburg contributes to practical research on chronic digestive disorders.

In eye diseases, clinical trials at this site are centered on geographic atrophy, a serious form of vision loss linked to age-related macular degeneration. The research is aimed at slowing disease progression and evaluating new treatment options that may help preserve sight.

• Studies on slowing geographic atrophy progression
• Evaluation of novel therapies for retinal degeneration
• Research focused on preserving vision and functional eye health

This work supports the search for more effective approaches to managing progressive eye disease in older adults.

Trials in hemic and lymphatic diseases at the hospital address thromboembolic disease, deep vein thrombosis, and bleeding risk in patients using blood thinners. The main purpose is to improve clot prevention and treatment while keeping safety in focus.

• Prevention and treatment of venous thromboembolism
• Studies on clot breakdown and anticoagulation reversal
• Safety research for patients needing urgent procedures while on anticoagulants

These studies help clarify how to balance clot prevention with bleeding risk in everyday clinical care.

In neoplasms, the site is involved in research on melanoma. The trials are designed to test new cancer treatment strategies and improve outcomes after surgery, with a focus on reducing the chance that the disease returns.

• Treatment research for melanoma after resection
• Studies evaluating cancer recurrence prevention
• Work aimed at improving survival and disease control in skin cancer

This area reflects the hospital’s contribution to modern oncology research, especially in treatments that support longer-lasting remission.

Clinical trials in nervous system diseases include research on migraine, with a particular interest in treatment options for children and adolescents. The goal is to assess how well new therapies help relieve acute symptoms while remaining safe and tolerable for younger patients.

• Pediatric migraine treatment research
• Studies on symptom relief and medication tolerability
• Support for better headache care in younger age groups

This pediatric focus fits the department’s expertise and highlights research aimed at improving day-to-day care for children with neurological conditions.

Research in virus diseases includes studies on RSV in older adults and cytomegalovirus during pregnancy. These trials are intended to improve prevention, strengthen immune protection, and reduce the burden of viral infections in vulnerable groups.

• Prevention of RSV-associated disease in older adults
• Maternal and neonatal protection against CMV
• Evaluation of vaccines and antiviral strategies for infection control

The site’s viral research combines adult and maternal-child health perspectives, showing a broad interest in infection prevention across age groups.